SCHEMBL6175385

SCHEMBL6175385

FC(F)(F)c1cccc(N2CCN(CCc3ccc4ccncc4c3)CC2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.64
HTR1A P08908 10/20 0.63
ALDH1A1 P00352 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
MAPT P10636 1/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
MAPK1 P28482 1/20 0.63
CYP2C19 P33261 1/20 0.63
THPO P40225 1/20 0.63
MTOR P42345 1/20 0.63
BLM P54132 1/20 0.63
PMP22 Q01453 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
KDM4E B2RXH2 1/20 0.59
POLB P06746 1/20 0.59
DRD2 P14416 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401478 0.82 DRD2 (0.56) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL6480903 0.81 SIGMAR1 (0.64) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL3454609 0.78 SIGMAR1 (1.00) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL31513986 0.78 ALDH1A1 (1.00) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL14410956 0.78 HTR1A (1.00) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL3976547 0.78 ALDH1A1 (1.00) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
SCHEMBL1401365 0.78 DRD2 (0.56) SIGMAR1HTR1AALDH1A1CYP1A2CYP3A4
Ssr-150106 SCHEMBL29393331 0.77 SIGMAR1 (0.48) SIGMAR1MAPTKDM4EDRD2DRD3
Ssr-150106 SCHEMBL1385047 0.77 SIGMAR1 (0.48) SIGMAR1MAPTKDM4EDRD2DRD3
Hydrochloric Acid SCHEMBL4589565 0.77 DRD2 (0.55) HTR1AALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209216-A1 Phenyl-and pyridyl-diazaheterocycles having a tnf-modulating activity SANOFI-AVENTIS (FR) 2005-09-22 US disclosed
EP-1517896-A2 PHENYL- AND PYRIDYL-DIAZAHETEROCYCLES HAVING A TNF-MODULATING ACTIVITY Sanofi-Aventis (FR) 2005-03-30 EP disclosed
WO-2003106425-A2 PHENYL- AND PYRIDYL-DIAZAHETEROCYCLES HAVING A TNF-MODULATING ACTIVITY SANOFI-SYNTHELABO (FR) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209216-A1 Phenyl-and pyridyl-diazaheterocycles having a tnf-modulating activity TNF, TNFRSF1A, CD40 SIGMAR1 498/4885HTR1A 397/4885ALDH1A1 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.